News & Updates

Show Multimedia Only

Is it safe to take NSAIDs when using oral anticoagulants?

09 Dec 2025 by

The use of oral anticoagulants (OACs) with NSAIDs results in clinical outcomes like those of OAC monotherapy, a study has shown.

Is it safe to take NSAIDs when using oral anticoagulants?

09 Dec 2025

Tobevibart–elebsiran combo demonstrates therapeutic potential against hepatitis D

09 Dec 2025

Patients with chronic hepatitis D virus (HDV) infection appear to respond to treatment with the combination of tobevibart plus elebsiran, according to the phase II, open-label SOLSTICE trial.

Tobevibart–elebsiran combo demonstrates therapeutic potential against hepatitis D

09 Dec 2025

PPI use hurts survival outcomes in glioblastoma

08 Dec 2025

In patients with newly diagnosed glioblastoma, the use proton pump inhibitors (PPI) may be detrimental to survival, according to a meta-analysis.

PPI use hurts survival outcomes in glioblastoma

08 Dec 2025

Oral triterpenoid antifungal works against recurrent vulvovaginal candidiasis

07 Dec 2025 by

Treatment with the first-in-class oral nonazole, triterpenoid antifungal ibrexafungerp appears to be efficacious and well-tolerated in patients with recurrent vulvovaginal candidiasis, as shown in the phase III CANDLE study.

Oral triterpenoid antifungal works against recurrent vulvovaginal candidiasis

07 Dec 2025

Nipocalimab shows promise in Sjögren's disease

07 Dec 2025

Treatment with nipocalimab is safe and helps improve clinical disease activity in patients with moderate-to-severe, active Sjögren's disease, according to the phase II DAHLIAS trial.

Nipocalimab shows promise in Sjögren's disease

07 Dec 2025

Olezarsen reduces triglycerides, pancreatitis risk in severe hypertriglyceridaemia

06 Dec 2025 by

Treatment with olezarsen significantly reduced triglyceride levels and the risk of acute pancreatitis in patients with severe hypertriglyceridaemia, according to the primary results of the CORE-TIMI 72a and CORE2-TIMI 72b trials presented at AHA 2025.

Olezarsen reduces triglycerides, pancreatitis risk in severe hypertriglyceridaemia

06 Dec 2025

Oral corticosteroids confer little to no GDM risk for expectant mothers

05 Dec 2025 by

Exposure to oral corticosteroids during pregnancy is not associated with the risk of gestational diabetes mellitus (GDM), except for a modest increase during an early exposure window, as shown in a study from South Korea.

Oral corticosteroids confer little to no GDM risk for expectant mothers

05 Dec 2025

In-utero exposure to INSTI-based ART regimens not a hazard to infant neurodevelopment

05 Dec 2025

Infants exposed to antiretroviral treatment (ART) regimens containing integrase strand transfer inhibitors (INSTIs) in utero seem to fare as well as their nonexposed peers in terms of neurodevelopment, as reported in a study.

In-utero exposure to INSTI-based ART regimens not a hazard to infant neurodevelopment

05 Dec 2025

Relapse higher in HBeAg- patients after cessation of TAF vs TDF, entecavir

04 Dec 2025

Patients who discontinue tenofovir alafenamide (TAF) therapy appear to have a higher hepatitis B virus relapse rate than those who ceased entecavir or tenofovir disoproxil fumarate (TDF) therapy, according to a recent study.

Relapse higher in HBeAg- patients after cessation of TAF vs TDF, entecavir

04 Dec 2025

Does aspirin use worsen IBD severity in pregnant women?

04 Dec 2025

The use of aspirin among pregnant patients with inflammatory bowel disease (IBD) does not appear to increase the risk of disease severity, reports a study. Low-dose aspirin (LDA) has been prescribed to nearly a third of IBD patients during pregnancy.

Does aspirin use worsen IBD severity in pregnant women?

04 Dec 2025

News & Updates

Filter by Specialty:

Specialty:

Is it safe to take NSAIDs when using oral anticoagulants?

Is it safe to take NSAIDs when using oral anticoagulants?

Tobevibart–elebsiran combo demonstrates therapeutic potential against hepatitis D

Tobevibart–elebsiran combo demonstrates therapeutic potential against hepatitis D

PPI use hurts survival outcomes in glioblastoma

PPI use hurts survival outcomes in glioblastoma

Oral triterpenoid antifungal works against recurrent vulvovaginal candidiasis

Oral triterpenoid antifungal works against recurrent vulvovaginal candidiasis

Nipocalimab shows promise in Sjögren's disease

Nipocalimab shows promise in Sjögren's disease

Olezarsen reduces triglycerides, pancreatitis risk in severe hypertriglyceridaemia

Olezarsen reduces triglycerides, pancreatitis risk in severe hypertriglyceridaemia

Oral corticosteroids confer little to no GDM risk for expectant mothers

Oral corticosteroids confer little to no GDM risk for expectant mothers

In-utero exposure to INSTI-based ART regimens not a hazard to infant neurodevelopment

In-utero exposure to INSTI-based ART regimens not a hazard to infant neurodevelopment

Relapse higher in HBeAg- patients after cessation of TAF vs TDF, entecavir

Relapse higher in HBeAg- patients after cessation of TAF vs TDF, entecavir

Does aspirin use worsen IBD severity in pregnant women?

Does aspirin use worsen IBD severity in pregnant women?